Squarepoint’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $333K | Sell |
3,214
-171,819
| -98% | -$19.5M | ﹤0.01% | 3628 |
|
|
2025
Q4 | $17.6M | Sell |
175,033
-187,224
| -52% | -$20.3M | 0.02% | 797 |
|
|
2025
Q3 | $44.7M | Sell |
362,257
-81,430
| -18% | -$10.1M | 0.04% | 442 |
|
|
2025
Q2 | $53.3M | Sell |
443,687
-252,251
| -36% | -$33.7M | 0.06% | 386 |
|
|
2025
Q1 | $102M | Buy |
695,938
+126,028
| +22% | +$19.2M | 0.12% | 149 |
|
|
2024
Q4 | $92.6M | Buy |
569,910
+206,249
| +57% | +$33.7M | 0.09% | 209 |
|
|
2024
Q3 | $59.2M | Buy |
363,661
+133,922
| +58% | +$19.8M | 0.09% | 202 |
|
|
2024
Q2 | $31.4M | Buy |
229,739
+136,164
| +146% | +$18.9M | 0.05% | 394 |
|
|
2024
Q1 | $14.3M | Buy |
93,575
+42,535
| +83% | +$6.35M | 0.02% | 784 |
|
|
2023
Q4 | $7.28M | Sell |
51,040
-199,504
| -80% | -$26.6M | 0.01% | 1143 |
|
|
2023
Q3 | $32.8M | Sell |
250,544
-235,425
| -48% | -$35.8M | 0.08% | 276 |
|
|
2023
Q2 | $77.3M | Sell |
485,969
-69,129
| -12% | -$11.2M | 0.24% | 71 |
|
|
2023
Q1 | $87.8M | Buy |
555,098
+451,760
| +437% | +$67.7M | 0.36% | 32 |
|
|
2022
Q4 | $14.5M | Sell |
103,338
-361,576
| -78% | -$51.3M | 0.06% | 362 |
|
|
2022
Q3 | $59.7M | Sell |
464,914
-21,548
| -4% | -$3.11M | 0.3% | 47 |
|
|
2022
Q2 | $68.6M | Buy |
486,462
+386,055
| +384% | +$55.2M | 0.38% | 47 |
|
|
2022
Q1 | $14M | Sell |
100,407
-182,170
| -64% | -$27.9M | 0.06% | 349 |
|
|
2021
Q4 | $49.3M | Sell |
282,577
-36,174
| -11% | -$6.03M | 0.13% | 132 |
|
|
2021
Q3 | $52.8M | Buy |
318,751
+203,776
| +177% | +$35.1M | 0.15% | 130 |
|
|
2021
Q2 | $20.7M | Buy |
114,975
+33,326
| +41% | +$6.08M | 0.08% | 229 |
|
|
2021
Q1 | $15.7M | Sell |
81,649
-188,429
| -70% | -$36.3M | 0.09% | 228 |
|
|
2020
Q4 | $54.5M | Buy |
270,078
+224,647
| +494% | +$46.5M | 0.41% | 27 |
|
|
2020
Q3 | $9.55M | Sell |
45,431
-31,061
| -41% | -$6.92M | 0.13% | 187 |
|
|
2020
Q2 | $16.8M | Buy |
76,492
+69,885
| +1,058% | +$14M | 0.27% | 81 |
|
|
2020
Q1 | $1.15M | Sell |
6,607
-118,476
| -95% | -$19.6M | 0.03% | 668 |
|
|
2019
Q4 | $19.2M | Sell |
125,083
-160,593
| -56% | -$24M | 0.11% | 154 |
|
|
2019
Q3 | $43.4M | Buy |
285,676
+267,546
| +1,476% | +$42.3M | 0.39% | 39 |
|
|
2019
Q2 | $2.78M | Buy |
18,130
+11,474
| +172% | +$1.75M | 0.03% | 676 |
|
|
2019
Q1 | $1.07M | Buy |
+6,656
| New | +$1.03M | 0.01% | 1076 |
|
|
2017
Q4 | – | Sell |
-34,607
| Closed | -$4.57M | – | 2111 |
|
|
2017
Q3 | $4.57M | Buy |
34,607
+22,186
| +179% | +$2.98M | 0.09% | 295 |
|
|
2017
Q2 | $1.66M | Sell |
12,421
-764
| -6% | -$103K | 0.03% | 574 |
|
|
2017
Q1 | $1.78M | Buy |
+13,185
| New | +$1.71M | 0.05% | 422 |
|
|
2016
Q4 | – | Sell |
-6,508
| Closed | -$815K | – | 1785 |
|
|
2016
Q3 | $815K | Sell |
6,508
-444
| -6% | -$58.2K | 0.05% | 402 |
|
|
2016
Q2 | $962K | Sell |
6,952
-9,631
| -58% | -$1.25M | 0.06% | 361 |
|
|
2016
Q1 | $2.09M | Buy |
16,583
+14,487
| +691% | +$1.84M | 0.16% | 164 |
|
|
2015
Q4 | $266K | Sell |
2,096
-23,493
| -92% | -$2.92M | 0.03% | 856 |
|
|
2015
Q3 | $2.96M | Buy |
25,589
+22,858
| +837% | +$2.57M | 0.74% | 33 |
|
|
2015
Q2 | $284K | Buy |
+2,731
| New | +$295K | 0.09% | 307 |
|
Other funds holding CLX
VCM
VPM
DAM
Squarepoint's CLX Position: Q1 2026 in Review
Squarepoint reduced its Clorox (CLX) stake by 98% in Q1 2026, selling an estimated $19.5M and leaving 3,214 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #3628.
Squarepoint first reported a position in CLX in Q2 2015 and has held it in 38 quarters since. The position peaked at $102M in Q1 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Squarepoint held 3,214 shares of Clorox worth $333K as of Q1 2026.
- Squarepoint sold 171,819 Clorox shares in Q1 2026, an estimated $19.5M.
- Clorox made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3628 holding.
- Squarepoint first reported a position in Clorox in Q2 2015 and has held it in 38 quarters since.
- Squarepoint's Clorox position peaked at $102M in Q1 2025.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.